Abstract
The structural analysis of protein-protein interactions and the prediction of their functional properties are important areas in modern structural bioinformatics. First, we review concepts for classifying protein-protein interactions, and for analyzing the geometry and composition of binding interfaces. Next, computational methods are discussed that allow predicting hot-spot residues and the kinetics and the rmodynamics of binding. Then, we focus on the mode of action of small molecule effectors that may either act as competitive antagonists of protein binders or as allosteric modulators. Here, we emphasize the roles of pre-formed or transiently open ligand-binding pockets at protein-protein interfaces. The presentation is rounded up by an overview over databases on protein-protein and protein-small-molecule interactions.
Keywords: Allosteric modulator, binding interface, competitive antagonist, hot-spot residue, obligate interaction, protein complex classification, protein-protein database, PDK1, transient binding pocket, molecule
Current Bioinformatics
Title:Bioinformatics of Protein-Protein Interfaces and Small Molecule Effectors
Volume: 7 Issue: 2
Author(s): Peter Walter, Ozlem Ulucan, Jennifer Metzger and Volkhard Helms
Affiliation:
Keywords: Allosteric modulator, binding interface, competitive antagonist, hot-spot residue, obligate interaction, protein complex classification, protein-protein database, PDK1, transient binding pocket, molecule
Abstract: The structural analysis of protein-protein interactions and the prediction of their functional properties are important areas in modern structural bioinformatics. First, we review concepts for classifying protein-protein interactions, and for analyzing the geometry and composition of binding interfaces. Next, computational methods are discussed that allow predicting hot-spot residues and the kinetics and the rmodynamics of binding. Then, we focus on the mode of action of small molecule effectors that may either act as competitive antagonists of protein binders or as allosteric modulators. Here, we emphasize the roles of pre-formed or transiently open ligand-binding pockets at protein-protein interfaces. The presentation is rounded up by an overview over databases on protein-protein and protein-small-molecule interactions.
Export Options
About this article
Cite this article as:
Walter Peter, Ulucan Ozlem, Metzger Jennifer and Helms Volkhard, Bioinformatics of Protein-Protein Interfaces and Small Molecule Effectors, Current Bioinformatics 2012; 7 (2) . https://dx.doi.org/10.2174/157489312800604444
DOI https://dx.doi.org/10.2174/157489312800604444 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Aliphatic and Aromatic Oxidations, Epoxidation and S-Oxidation of Prodrugs that Yield Active Drug Metabolites
Current Medicinal Chemistry Bone Morphogenetic Protein-Smad Pathway as Drug Targets for Osteoporosis and Cancer Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets Angiogenesis Markers in Gynecological Tumors and Patents for Anti- Angiogenic Approach: Review
Recent Patents on Anti-Cancer Drug Discovery Cadmium as an Endocrine Disruptor in the Reproductive System
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) A Novel Approach to Anticancer Therapies: Peroxisome Proliferator Activator-Receptor-γ as a New Target Therapy in the Treatment of Human Urological Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets CEBP Epigenetic Dysregulation as a Drug Target for the Treatment of Hematologic and Gynecologic Malignancies
Current Drug Targets Vertebrate Protein CTCF and its Multiple Roles in a Large-Scale Regulation of Genome Activity
Current Genomics Negative Glucocorticoid Receptor Response Elements and their Role in Glucocorticoid Action
Current Pharmaceutical Design Synthesis, Biological Evaluation and Molecular Dynamics Simulation Studies of Novel Diphenyl Ethers
Medicinal Chemistry Targeting the Folate Receptor: Improving Efficacy in Inorganic Medicinal Chemistry
Current Medicinal Chemistry Anti-Angiogenesis in the Treatment of Genito-Urinary Cancers: Last Updates
Current Angiogenesis (Discontinued) Drug Transport Across the Placenta
Current Pharmaceutical Biotechnology Cubilin, the Intrinsic Factor-Vitamin B12 Receptor in Development and Disease
Current Medicinal Chemistry Urokinase-type Plasminogen Activator (uPA) and its Receptor (uPAR): Development of Antagonists of uPA / uPAR Interaction and their Effects In Vitro and In Vivo
Current Pharmaceutical Design Endometriosis and Perinatal Outcome - A Systematic Review of the Literature
Current Women`s Health Reviews Metastatic Brain Tumors: To Treat or Not to Treat, and with What?
Current Cancer Therapy Reviews Patent Analysis as a Tool for Research Planning: Study on Natural Based Therapeutics Against Cancer Stem Cells
Recent Patents on Anti-Cancer Drug Discovery Sodium Dependent Multivitamin Transporter (SMVT): A Potential Target for Drug Delivery
Current Drug Targets Sinonasal Carcinoma: Updated Phenotypic and Molecular Characterization
Current Cancer Therapy Reviews Activin Receptor-Like Kinases: Structure, Function and Clinical Implications
Endocrine, Metabolic & Immune Disorders - Drug Targets